Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GT20029 for Androgenetic Alopecia in Chinese Adult Males
NCT06692465Phase 2Completed
- Sponsor
- Kintor Pharmaceutical Limited
- Start
- Apr 2023
- Primary completion
- Dec 2023
- Modality
- Bivalent/Multivalent Binders, PROTACs (E3 ligase recruitment)
- Countries
- 1
01
Overview
A Phase 2 trial of GT20029 in androgenetic alopecia (AGA), sponsored by Kintor Pharmaceutical Limited. Started Apr 2023; status: completed.
02
Drugs
GT20029
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06692465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06692465.